Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ci 716
2. Ci-716
3. Ci716
4. Flupyrazapon
5. Flupyrazopon
6. Hydrochloride, Zolazepam
7. Zolasepam
8. Zolazepam
1. Zolazepam Hcl
2. 33754-49-3
3. Ci-716
4. 45sj093q1n
5. 4-(2-fluorophenyl)-1,3,8-trimethyl-6h-pyrazolo[3,4-e][1,4]diazepin-7-one;hydrochloride
6. 4-(o-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo(3,4-e)(1,4)diazepin-7(1h)-one Monohydrochloride
7. Pyrazolo(3,4-e)(1,4)diazepin-7(1h)-one, 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-, Monohydrochloride
8. Unii-45sj093q1n
9. Zolazepam Hydrochloride [usan]
10. Einecs 251-668-7
11. Zolazepam Hydrochloride [usan:usp]
12. Schembl73002
13. Zolazepam Hydrochloride (usp)
14. Chembl2107559
15. Dtxsid00955349
16. Zolazepam Hydrochloride(500 Mg)
17. Zolazepam Hydrochloride [mi]
18. Zolazepam Hydrochloride [usp-rs]
19. Zolazepam Hydrochloride [green Book]
20. Ft-0775057
21. Zolazepam Hydrochloride [usp Impurity]
22. D06377
23. Zolazepam Hydrochloride [usp Monograph]
24. Q27258863
25. 4-(2-fluorophenyl)-1,3,8-trimethyl-6h-pyrazolo[3,4-e][1,4]diazepin-7-one,hydrochloride
26. 4-(2-fluorophenyl)-1,3,8-trimethyl-6,8-dihydropyrazolo[3,4-e][1,4]diazepin-7(1h)-one--hydrogen Chloride (1/1)
27. 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo(3,4-e)(1,4)diazepin-7(1h)-one Monohydrochloride
28. 42551-17-7
29. Pyrazolo(3,4-e)(1,4)diazepin-7(1h)-one, 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-, Hydrochloride
Molecular Weight | 322.76 g/mol |
---|---|
Molecular Formula | C15H16ClFN4O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 322.0996670 g/mol |
Monoisotopic Mass | 322.0996670 g/mol |
Topological Polar Surface Area | 50.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 455 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
ABOUT THIS PAGE
94
PharmaCompass offers a list of Zolazepam Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zolazepam Hydrochloride manufacturer or Zolazepam Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zolazepam Hydrochloride manufacturer or Zolazepam Hydrochloride supplier.
PharmaCompass also assists you with knowing the Zolazepam Hydrochloride API Price utilized in the formulation of products. Zolazepam Hydrochloride API Price is not always fixed or binding as the Zolazepam Hydrochloride Price is obtained through a variety of data sources. The Zolazepam Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zolazepam Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zolazepam Hydrochloride, including repackagers and relabelers. The FDA regulates Zolazepam Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zolazepam Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zolazepam Hydrochloride supplier is an individual or a company that provides Zolazepam Hydrochloride active pharmaceutical ingredient (API) or Zolazepam Hydrochloride finished formulations upon request. The Zolazepam Hydrochloride suppliers may include Zolazepam Hydrochloride API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zolazepam Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zolazepam Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zolazepam Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zolazepam Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zolazepam Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zolazepam Hydrochloride suppliers with NDC on PharmaCompass.
Zolazepam Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zolazepam Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zolazepam Hydrochloride GMP manufacturer or Zolazepam Hydrochloride GMP API supplier for your needs.
A Zolazepam Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Zolazepam Hydrochloride's compliance with Zolazepam Hydrochloride specifications and serves as a tool for batch-level quality control.
Zolazepam Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Zolazepam Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zolazepam Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Zolazepam Hydrochloride EP), Zolazepam Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zolazepam Hydrochloride USP).